Keiichiro Miyajima

13PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 21, 2026
Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.

|Sep 10, 2026
Cancer-Control Outcomes of Japanese Vs. German Metastatic Hormone-Sensitive Prostate Cancer Patients: A Real-World Cross-Country Comparison of Patients Undergoing Combination Therapies.

|May 22, 2026
First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.

|Mar 16, 2026
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis.

Navid Roessler, Marcin Miszczyk, Paolo Gontero

|Sep 03, 2024
Transplant renal vein thrombosis and stenosis were rescued by interventional radiology.

Naoki Uchida, Keiichiro Miyajima, Takafumi Yanagiswa

|Jul 22, 2024
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.

Fumihiko Urabe, Yu Imai, Yuma Goto

Pageof 3

Frequent Collaborators

10 joint publications

Fumihiko Urabe

5 joint publications

Shunsuke Tsuzuki

3 joint publications

Wataru Fukuokaya

3 joint publications

Takafumi Yanagisawa